2H-2,4a-Methanonaphthalen-1(5H)-one, hexahydro-5,5-dimethyl-
Common Name: |
2H-2,4a-Methanonaphthalen-1(5H)-one, hexahydro-5,5-dimethyl- |
IUPAC Name: |
2,2-dimethyl-octahydro-1H-2,4a-methanonapthalen-8-one |
Molecular Formula: |
C9H15NO |
SMILES: |
CC1(CCCC2C13CCC(C3)C2=O)C |
Inchi: |
1S/C13H20O/c1-12(2)6-3-4-10-11(14)9-5-7-13(10,12)8-9/h9-10H,3-8H2,1-2H3 |
Inchi Key: |
BFQXSHITVXYCMS-UHFFFAOYSA-N |
Cas No: |
77923-74-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
153.22 |
Mass (g/mol) |
192.151 |
Molar Refractivity |
45.74 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
6 |
Rings |
3 |
TPSA |
33.02 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
3.182 |
iLOGP |
2.36 |
XLOGP3 |
1.54 |
WLOGP |
2.27 |
MLOGP |
1.36 |
ESOL Log S |
-1.36 |
ESOL Solubility (mg/ml) |
6.62 |
ESOL Solubility (mol/l) |
0.043 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.84 |
Ali Solubility (mg/ml) |
2.2 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.19 |
Silicos-IT Solubility (mg/ml) |
0.99 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.14 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.124 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.135 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
1 |
OCT2 inhibitor |
0 |